China Pharma Holdings, Inc. (CPHI) Reports Q3 Loss of $0.05

China Pharma Holdings, Inc. (NYSE: CPHI) reported Q3 EPS of ($0.05). Revenue for the quarter came in at $3.2 million.

Third Quarter Highlights

• Revenues were $3.2 million and $3.1 million for the three months ended September 30, 2017 and 2016 respectively;
• Gross profit margin was 13.3% in third quarter 2017, compared to 11.2% in the same period of 2016.
• Loss from operations was $2.1 million in third quarter 2017 compared to $1.5 million in the same period of 2016;
• Net loss was $2.2 million in third quarter 2017 compared to $1.7 million in the same period of 2016. Loss per common share was $(0.05) per basic and diluted share in third quarter 2017 compared with $(0.04) per basic and diluted share in the same period of 2016.

For earnings history and earnings-related data on China Pharma Holdings, Inc. (CPHI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c